Skip to main content
Log in

Structure-activity relationships in β-adrenoblockers

  • Search for New Drugs
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literature cited

  1. L. N. Borisova, O. M. Glozman, Sh. I. Ismailov, et al., Khim.-farm. Zh., No. 1, 41–45 (1989).

    Google Scholar 

  2. V. S. Gasilin and B. A. Sidorenko, Stenocardia.(in Russian], Moscow (1981).

  3. O. M. Glozman, L. N. Borisova, V. I. Kuz'min, et al., Khim.-farm. Zh., No. 1, 38–41 (1989).

    Google Scholar 

  4. I. V. Duba, G. I. Gerasimovich, and A. I. Balakleevskaya, Akush. Ginekol., No. 10, 32–35 (1981).

    Google Scholar 

  5. V. N. Ermakova, Vestn. Oftal'mol., No. 5, 10–13 (1981).

    Google Scholar 

  6. I. V. Komissarov and I. I. Abramets, Usp. Fiziol. Nauk, No. 2, 75–93 (1977).

    Google Scholar 

  7. D. V. Preobrazhenskii, Ter. Arkh., No. 12, 123–128 (1984).

    Google Scholar 

  8. D. P. Polukordas and V. V. Daukshas, New Drugs [in Russian], Moscow (1975), pp. 26–52.

  9. I. B. Simon, V. P. Vvedenskii, I. I. Levshina, et al., Khim.-farm. Zh., No. 3, 7–9 (1974).

    Google Scholar 

  10. E. I. Chazov and V. I. Metelitsa, ibid., No. 10, 3–12 (1979).

    Google Scholar 

  11. V. F. Shmyreva, N. V. Fridman, and N. V. Makasheva, Vestn. Oftal'mol., No. 3, 8–10 (1982).

    Google Scholar 

  12. E. V. érina, Kardiologiya, No. 9, 114–121 (1980).

    Google Scholar 

  13. B. Ablad and E. Ek. L. Caisson, Life Sci.,12, 107–112 (1973).

    Google Scholar 

  14. K. R. Adam, J. R. C. Baird, R. A. Burges, and J. Linnell, Eur. J. Pharmacol.,25, 170–175.

  15. W. H. Aellig, Br. J. Pharmacol.,47, 621P (1973).

  16. W. H. Aellig, J. Cardiovasc. Pharmacol.,5, Suppl. 1, 516–520 (1983).

    Google Scholar 

  17. G. Allan, D. Cambridge, G. W. Hardy, et al., J. Hypertens.,4, Suppl. 6, 131–133 (1986).

    Google Scholar 

  18. H. L. Ammon, K. El-Sayed, S. M. Prasad, et al., Acta Crystallogr.,42, 446–452 (1986).

    Google Scholar 

  19. Y. Antonio, C. Camargo, E. Galearri, et al., J. Med. Chem.,21, 123–126 (1978).

    Google Scholar 

  20. E. J. Ariens and A. M. Simonis, Beta-Adrenoreceptor Blocking Agents, Amsterdam (1976), pp. 3–27.

  21. W. S. Aronow and R. R. Uyeyama, Clin. Pharmacol. Ther.,13, 15–22 (1982).

    Google Scholar 

  22. D. Atlas, M. L. Steer, and A. Levitzki, Proc. Natl. Acad. Sci.,73, 1921–1925 (1976).

    Google Scholar 

  23. J. J. Augstein, D. A. Cox, A. L. Ham, et al., J. Med. Chem. 16, 1245–1251 (1973).

    Google Scholar 

  24. J. J. Baldwin, E. L. Engelhardt, R. Hirschmann, and G. S. Ponticello, ibid.,23, 65–70 (1980).

    Google Scholar 

  25. J. J. Baldwin, G. H. Denny, R. Hirschmann, et al., ibid.,26, 950–957 (1983).

    Google Scholar 

  26. J. J. Baldwin, M. E. Christy, G. H. Denny, et al., ibid.,29, 1065–1080 (1986).

    Google Scholar 

  27. J. J. Barlow, B. G. Main, J. A. Moors, et al., Br. J. Pharmacol.,67, 412–418 (1979).

    Google Scholar 

  28. J. J. Barlow, B. J. Main, and H. M. Snow, J. Med. Chem.,24, 315–322 (1981).

    Google Scholar 

  29. A. M. Barrett, Drug Design, Vol. 3, London (1972), pp. 205–228.

    Google Scholar 

  30. A. M. Barrett, J. Carter, J. D. Fitzgerald, et al., Br. J. Pharmacol.,48, 340P (1973).

  31. W. Bartsch, K. Dietmann, J. Leinert, and G. Sponer, Arzneim.-Forsch.,27, 1022–1026 (1977).

    Google Scholar 

  32. W. Bartsch, G. Sponer, K. Strien, et al., Therapiewoche,32, 5714–5719 (1982).

    Google Scholar 

  33. B. Basil and R. Jordan, Eur. J. Pharmacol.,80, 47–56 (1982).

    Google Scholar 

  34. R. Berthold, R. Waite, and H. Weber, Br. J. Pharmacol.,74, 829P (1981).

  35. J. P. Bilezikian, A. M. Dornfeld, and D. Gammon, Biochem. Pharmacol.,27, 1455–1461 (1978).

    Google Scholar 

  36. A. Bilski, S. Dorries, and J. D. Fitzgerald, Br. J. Pharmacol.,69, 292P (1980).

  37. J. W. Black and J. S. Stephenson, Lancet,2, 311–314 (1962).

    Google Scholar 

  38. J. W. Black, A. F. Crowter, R. G. Shanks, et al., ibid.,1, 1080–1081 (1964).

    Google Scholar 

  39. J. R. Boissier, R. Ratouis, C. Dumont, et al., J. Med. Chem.,13, 971–973 (1970).

    Google Scholar 

  40. J. R. Boissier, R. Goutte, C. Advenier, and J.-F. Giudicelli, Therapie,28, 1251–1265 (1973).

    Google Scholar 

  41. J. P. Boudot, J. Cavero, S. Fenard, et al., Br. J. Pharmacol.,66, 445P (1979).

  42. E. Bouley, J.-M. Teulin, M. Cazes, et al., J. Med. Chem.,29, 100–103 (1986).

    Google Scholar 

  43. M. Bouzoubaa, G. Leclerc, N. Decker, et al., ibid.,27, 1291–1294 (1984).

    Google Scholar 

  44. A. Brandstrom, H. Corrodi, U. Junggren, and T. E. Jonsson, Acta Pharm. Suec.,3, 303–310 (1966).

    Google Scholar 

  45. Brefonalol, Drug License Opport., Dec. 5 (1988), p. 2051.

  46. J. J. Burgess, Med. Prog.,13, 22–31 (1986).

    Google Scholar 

  47. M. Carissimi, P. Gentili, E. Grumelli, et al., Arzneim.-Forsch.,26, 506–516 (1976).

    Google Scholar 

  48. M.-Ch. Carre, A. Youlassani, P. Caubere, et al., J. Med. Chem.,27, 792–798 (1984).

    Google Scholar 

  49. S. G. Carruthers, J.-P. Hosler, P. Pentikainen, and D. L. Azarnoff, Clin. Pharmacol. Ther.,24, 168–174 (1978).

    Google Scholar 

  50. C. Castagnino, S. Corsaco, G. Strappaghetti, et al., Farmaco, Ed. Sci.,38, 679–685 (1983).

    Google Scholar 

  51. I. Cavero, F. Levevre-Borg, and P. Manoury, Br. J. Pharmacol.,84, Suppl., P 31P (1985).

  52. V. Cecchetti, et al., Farmaco, Ed. Sci.,42, 61–75 (1987).

    Google Scholar 

  53. M. S. Chodnecar, A. F. Crowther, W. Hepworth, et al., J. Med. Chem.,15, 49–57 (1972).

    Google Scholar 

  54. B. J. Clark, K. Saameli, and F. Troxter, Proc. Br. Pharmacol. Sci., 123 (1974).

  55. B. J. Clark, Beta-Adrenoreceptor Blocking Agents, Amsterdam (1976), pp. 45–78.

  56. B. J. Clark, Vasc. Med.,2, 17–25 (1985).

    Google Scholar 

  57. M. A. Commarato, H. C. Giardino, G. A. Kopin, and H. R. Kaplan, Arch. Int. Pharmacodyn. Ther.,226, 205–212 (1977).

    Google Scholar 

  58. S. Conde, C. Corral, R. Madronero, et al., J. Med. Chem.,20, 970–974 (1977).

    Google Scholar 

  59. S. Conde, C. Corral, J. Lissavetzky, et al., Eur. J. Med. Chem.,18, 151–154 (1983).

    Google Scholar 

  60. M. E. Condon, C. M. Gimarusti, R. Fox, et al., J. Med. Chem.,21, 913–921 (1978).

    Google Scholar 

  61. H. Corradi, H. Persson, A. Carlsson, and J. Roberts, ibid.,6, 751–755 (19630.

  62. C. R. Crooks, J. Wright, P. S. Callery, and J. E. Moreton, ibid.,22, 210–214 (1979).

    Google Scholar 

  63. A. F. Crowther and L. H. Smith, ibid., 1009–1013 (1968).

    Google Scholar 

  64. A. F. Crowther, D. J. Gilman, B. J. McLoughlin, et al., ibid.,12, 638–646 (1969).

    Google Scholar 

  65. A. F. Crowther, R. Howe, B. J. McLoughlin, et al., ibid.,15, 260–266 (1972).

    Google Scholar 

  66. J. W. Daemmgent, G. Engelhardt, and H. Pelzer, Arzneim.-Forsch.,35, 383–390 (1985).

    Google Scholar 

  67. R. C. Dage, H. C. Cheng, C. P. Hsich, and J. K. Woodward, Fed. Proc.,37, 633–647 (1978).

    Google Scholar 

  68. P. Da Re, P. Valenti, G. Fabbri, et al., Drugs Exp. Res.,14, 687–692 (1988).

    Google Scholar 

  69. C. T. Dollery, J. Cardiovasc. Pharmacol.,11, Suppl. 2, 1–4 (1988).

    Google Scholar 

  70. D. J. Dooley and H. Bittager, International Congress of Pharmacology, No. 9, Abstracts, London (1984), p. 1009P.

  71. L. Dorigotti, G. Ferni, and C. Semerazo, ibid., 1906P.

  72. B. Dubois and M. G. Bousser, Therapie,40, 407–412 (1985).

    Google Scholar 

  73. D. Dunlop and R. G. Shanks, Br. J. Pharmacol.,32, 201–208 (1968).

    Google Scholar 

  74. L. H. Easson and E. Stedman, Biochem. J.,27, 1257–1266 (1933).

    Google Scholar 

  75. J. A. Edwards, B. Berkoz, G. S. Lewis, et al., J. Med. Chem.,17, 200–203 (1974).

    Google Scholar 

  76. P. W. Erhardt, C. M. Woo, W. C. Andersson, and R. J. Gorczynski, ibid.,25, 1408–1412 (1982).

    Google Scholar 

  77. A. Eschalier, G. Dureng, P. Duchene-Marullas, et al., Eur. J. Med. Chem.,18, 139–145 (1983).

    Google Scholar 

  78. M. Ezer, G. Shtacher, and M. Weinstock, J. Med. Chem.,21, 982–984 (1978).

    Google Scholar 

  79. J. Farmer, I. Kennedy, G. P. Levy, and R. J. Marshall, Br. J. Pharmacol.,45, 660–675 (1972).

    Google Scholar 

  80. J. Feely and N. Peden, Drugs,27, 425–446 (1984).

    Google Scholar 

  81. M. G. Fekete, Arch. Int. Pharmacodyn. Ther.,248, 190–202 (1980).

    Google Scholar 

  82. K. Femmer, R. Bartsch, U. Leonhardt, et al., Pharmazie,30, 642–651 (1975).

    Google Scholar 

  83. R. Ferrini, G. Miragoli, and G. Croce, Arzneim.-Forsch.,20, 1074–1079 (1970).

    Google Scholar 

  84. L. J. Findley and I. Cleeves, Lancet,1, 856 (1988).

    Google Scholar 

  85. G. A. Fothergill, Arzneim.-Forsch.,27, 978–981 (1977).

    Google Scholar 

  86. A. Franke, F. F. Frickel, J. Gries, et al., ibid.,30, 1831–1838 (1980).

    Google Scholar 

  87. A. Frankel, F. F. Frickel, J. Gries, et al., J. Med. Chem.,24, 1460–1464 (1981).

    Google Scholar 

  88. W. H. Frishman, Am. Heart J.,98, 526–535 (1979).

    Google Scholar 

  89. W. H. Frishman, ibid., 119–131.

    Google Scholar 

  90. W. H. Frishman, Clinical Pharmacology of β-Adrenergic Blocking Drugs, New York (1980).

  91. W. H. Frishman, N. Engl. J. Med.,305, 500–506 (1981).

    Google Scholar 

  92. W. H. Frishman, Int. J. Cardiol.,2, 165–178 (1982).

    Google Scholar 

  93. W. Fuhrer, F. Ostermayer, K. Zimmermann, et al., J. Med. Chem.,27, 831–836 (1984).

    Google Scholar 

  94. H. Galons, C. C. Farnoux, and M. Miocque, Eur. J. Med. Chem.,19, 23–27 (1984).

    Google Scholar 

  95. L. Garuti, A. Ferranti, G. Giovanninetti, and R. Gaggi, Farmaco, Ed. Sci.,38, 527–532 (1983).

    Google Scholar 

  96. J. F. Giudicelli, Therapie,35, 23–43 (1980).

    Google Scholar 

  97. T. Grandjean and L. Rivier, Cardiologia,49, 139–141 (1966).

    Google Scholar 

  98. J. Gries, L. Unger, J. Eining, et al., Arzneim.-Forsch.,38, 1271–1279 (1988).

    Google Scholar 

  99. D. Grimes, M. Stern, A. Wojdan, and J. R. Cummings, Can. J. Physiol. Pharmacol.,61, 1109–1115 (1983).

    Google Scholar 

  100. C. Guechot, A. Bertrand, P. Cramaille, and J. M. Teulon, Arzneim.-Forsch.,38, 655–660 (1988).

    Google Scholar 

  101. Y. Hara, E. Sato, A. Mivagishi, et al., Jpn. J. Pharmacol.,28, Suppl., 140P (1978).

  102. S. G. Hasting, R. D. Smith, R. M. Corey, et al., Arch. Int. Pharmacodyn. Ther.,226, 81–99 (1977).

    Google Scholar 

  103. R. C. Heel, R. N. Brogden, T. M. Speight, and G. S. Avery, Drugs,17, 38–55 (1979).

    Google Scholar 

  104. B. A. Hemsworth and J. A. Street, International Congress of Pharmacology, No. 7, Abstracts (Paris, 1978), p. 962.

    Google Scholar 

  105. P. H. Hernandez, H. E. Lape, and R. E. Philion, Fed. Proc.,38, 738–739 (1979).

    Google Scholar 

  106. N. Himori, A. Izumi, and Y. Hiramatsu, Arch. Int. Pharmacodyn. Ther.,220, 4–18 (1976).

    Google Scholar 

  107. W. Hoefke, W. Gaida, and A. Mentrup, Naunyn-Schmiedeberg's Arch. Pharmacol.,325, 1254 (1984).

    Google Scholar 

  108. M. L. Hoefle, S. G. Hastings, R. F. Meyer, et al., J. Med. Chem.,18, 148–152 (1975).

    Google Scholar 

  109. J. Hoekenda, L. David, and J. Abrams, Am. J. Med.,76, 309–314 (1984).

    Google Scholar 

  110. D. Horii, T. Kawada, K. Takeda, and S. Imai, Arzneim.-Forsch.,24, 1275–1286 (1974).

    Google Scholar 

  111. R. Howe and B. S. Rao, J. Med. Chem.,11, 1118–1121 (1968).

    Google Scholar 

  112. R. Howe, B. J. McLoughlin, B. S. Rao, et al., ibid.,12, 452–458 (1969).

    Google Scholar 

  113. R. Howe, B. S. Rao, and M. S. Chodnekar, ibid.,13, 169–176 (1970).

    Google Scholar 

  114. H. Hubner, K. Stephen, W. Meesmann, and R. R. Alendroth, Arzneim.-Forsch.,26, 1561–1565 (1976).

    Google Scholar 

  115. K. Ikezono, Jpn. J. Pharmacol., Suppl.,28, 149P (1978).

  116. H. Imamura, T. Nakamura, J. Inui, et al., Yakugaku Zasshi,92, 1039–1045 (1972).

    Google Scholar 

  117. J. L. Imbs, F. Miesch, and J. Schwartz, Br. J. Pharmacol.,60, 357–362 (1977).

    Google Scholar 

  118. R. Jackdish, M. Lederle, and G. Hertting, Arzneim.-Forsch.,35, 237–240 (1985).

    Google Scholar 

  119. H. Jacob, L. J. Brandt, F. Farkas, and W. Frishman, Am. J. Med.,74, 1042–1051 (1983).

    Google Scholar 

  120. B. Jamart-Gregoire, P. Caubere, M. Blank, et al., J. Med. Chem.,32, 315–320 (1989).

    Google Scholar 

  121. T. Jen and C. Kaiser, ibid.,20, 693–699 (1977).

    Google Scholar 

  122. G. Jennings, A. Bobik, and P. Korner, Br. J. Clin. Pharmacol.,12, 355–362 (1981).

    Google Scholar 

  123. S. T. Kam, W. L. Matier, K. X. Mai, et al., J. Med. Chem.,27, 1007–1016 (1984).

    Google Scholar 

  124. I. M. Katz, Ann. Ophthalmol.,10, 847–850 (1978).

    Google Scholar 

  125. J. Kennedy and G. P. Levy, Br. J. Pharmacol.,53, 585–592 (1975).

    Google Scholar 

  126. A. M. Khokhar, P. de Silva, R. F. Massey, and C. W. H. Havard, International Society of Hypertension, 6th Scientific Meeting, Coteborg (1979), Abstracts, p. 144.

  127. R. W. Kierstead, A. Faraone, F. Mennona, et al., J. Med. Chem.,26, 1561–1569 (1983).

    Google Scholar 

  128. K. H. Klinger, Drugs of the Future,7, 825–826 (1982).

    Google Scholar 

  129. W. E. Kreighbaum, W. L. Matier, R. D. Dennis, et al., J. Med. Chem.,23, 285–289 (1980).

    Google Scholar 

  130. K. Kubo, J. Nakamura, A. Karassawa, et al., Arzneim.-Forsch.,33, 926–931 (1983).

    Google Scholar 

  131. L. Lallos, V. Lappinet, G. Couderi, et al., J. Med. Chem.,24, 994–1001 (1981).

    Google Scholar 

  132. M. S. Large and L. H. Smith, ibid.,25, 1417–1422 (1982).

    Google Scholar 

  133. A. A. Larsen and P. M. Lish, Nature,203, 1283–1284 (1964).

    Google Scholar 

  134. M. Laubie, H. Schmitt, P. Mouille, et al., Arch. Int. Pharmacodyn. Ther.,201, 334–346 (1973).

    Google Scholar 

  135. G. Leclere, A. Mann, G. G. Wesmuth, et al., J. Med. Chem.,20, 1657–1662 (1977).

    Google Scholar 

  136. G. Leclerc, W. Bieth, and J. Schwartz, ibid.,23, 620–624 (1980).

    Google Scholar 

  137. G. Leclerc, Highlights Receptor Chemistry, Amsterdam (1984), pp. 109–133.

  138. R. J. Lee, D. B. Evans, S. H. Baky, and R. J. Laffan, Eur. J. Pharmacol.,33, 371–382 (1975).

    Google Scholar 

  139. P. H. le Fur, G. Schelk, P. Geynet, et al., Life Sci.,23, 1841–1950 (1978).

    Google Scholar 

  140. T. L. Lemke, M. B. Cramer, and S. W. Adamski, J. Med. Chem.,24, 1211–1216 (1981).

    Google Scholar 

  141. G. Leopold, J. Pabst, W. Ungethum, and K. U. Buring, Clin. Pharmacol. Ther.,31, 243–249 (1982).

    Google Scholar 

  142. B. Levy, J. Pharmacol. Exp. Ther.,156, 452–462 (1967).

    Google Scholar 

  143. B. Levy and B. E. Wilkenfeld, Eur. J. Pharmacol.,5, 227–234 (1969).

    Google Scholar 

  144. C. Lindner, Arzneim.-Forsch.,34, 270–276 (1984).

    Google Scholar 

  145. W. J. Louis, M. J. Rand, and J. J. McNeill, Cardiology,66, 96–104 (1979).

    Google Scholar 

  146. W. J. Louis, O. H. Drummer, and L. H. Tung, J. Cardiovasc. Pharmacol.,11, Suppl. 2, S5-S11 (1988).

    Google Scholar 

  147. K. Lovgren and A. Hedberg, J. Med. Chem.,24, 451–454 (1981).

    Google Scholar 

  148. D. I. Lowenthal, S. D. Saris, J. Packer, et al., Am. J. Med.,77, 119–127 (1984).

    Google Scholar 

  149. B. Lundgren, E. Carlsson, and L. Ek, Acta Physiol. Scand.,44, 508–513 (1982).

    Google Scholar 

  150. B. Macchia, A. Balsamo, A. Lapucci, et al., J. Med. Chem.,30, 616–622 (1987).

    Google Scholar 

  151. P. J. Machin, D. N. Hurst, R. M. Bradshaw, et al., ibid.,26, 1570–1576 (1983).

    Google Scholar 

  152. J. A. Macrae, Trans. Ophthalmol. Soc.,97, 510–520 (1977).

    Google Scholar 

  153. B. G. Main, J. Chem. Technol. Biotechnol.,32, 617–623 (1982).

    Google Scholar 

  154. B. G. Main and H. Tucker, Prog. Med. Chem.,22, 122–163 (1985).

    Google Scholar 

  155. A. J. Man in'tVeld and M. A. D. H. Schlekamp, J. Cardiovasc. Pharmacol.,5, Suppl. 1, 30–45 (1983).

    Google Scholar 

  156. E. Marmo, A. P. Caputi, and K. Saini, Arzneim.-Forsch.,22, 1109–1117 (1972).

    Google Scholar 

  157. A. Martinand, P. Corvol, and P. Millier, Therapie,38, 265–272 (1983).

    Google Scholar 

  158. D. G. McDevitt and B. N. C. Prochard, H. R. Coll. Physicans London,11, 21–34 (1976).

    Google Scholar 

  159. D. G. McDevitt, Med. Prog.,11, 19–20 (1984).

    Google Scholar 

  160. F. B. McGillon, Drugs of the Future,6, 555–556 (1981).

    Google Scholar 

  161. R. F. Meyer, C. D. Stratton, S. C. Hasting, and R. M. Corey, J. Med. Chem.,16, 1113–1116 (1973).

    Google Scholar 

  162. E. J. Mylecharane and C. Raper, Eur. J. Pharmacol.,29, 93–101 (1974).

    Google Scholar 

  163. Y. Nakagawa, T. Sugai, W.-P. Chin, et al., Arzneim.-Forsch.,34, 194–199 (1984).

    Google Scholar 

  164. M. Nakanishi, I. Muro, Y. Chihara, et al., J. Med. Chem.,15, 45–48 (1972).

    Google Scholar 

  165. J. A. Nathanson, Br. J. Pharmacol.,73, 97–100 (1981).

    Google Scholar 

  166. W. C. Nayler and J. Tay, J. Pharmacol. Exp. Ther.,180, 302–316 (1972).

    Google Scholar 

  167. M. Neuman, Drugs of the Future,7, 96–97 (1982).

    Google Scholar 

  168. D. M. Nganele, V. M. Leonardis, and T. H. Hinze, Br. J. Pharmacol.,93, 501–508 (1988).

    Google Scholar 

  169. R. M. Nicholson, J. C. Dearden, and P. J. Blakedge, J. Pharm. Pharmacol.,35, 92P (1983).

  170. A. Nuttall and H. M. Snow, Br. J. Pharmacol.,77, 381–388 (1982).

    Google Scholar 

  171. H. F. Oates, L. M. Stoker, and G. S. Stoker, Arch. Int. Pharmacodyn. Ther.,251, 95–102 (1981).

    Google Scholar 

  172. H. Obase, H. Tatsuno, K. Goto, et al., Chem. Pharm. Bull.,26, 1443–1452 (1978).

    Google Scholar 

  173. S. R. O'Donnell, W. Kaum, and J. C. Wanstall, Br. J. Pharmacol.,68, 705–710 (1980).

    Google Scholar 

  174. K. Ondrias, A. Stanko, V. Jancinova, and P. Balgavy, Mol. Pharmacol.,31, 97–103 (1987).

    Google Scholar 

  175. J. Pitha, B. A. Hughes, J. W. Kusiak, et al., Proc. Natl. Acad. Sci. USA,79, 4424–4427 (1982).

    Google Scholar 

  176. H. Pittner, Arzneim.-Forsch.,33, 13–25 (1983).

    Google Scholar 

  177. H. Pouleur, M. Rousseau, and L. A. Brasseur, Eur. J. Clin. Invest.,12, Suppl. 11, 49–55 (1982).

    Google Scholar 

  178. C. E. Powell and J. H. Slater, J. Pharmacol. Exp. Ther.,122, 480–488 (1958).

    Google Scholar 

  179. B. N. C. Prochard and C. W. Owens, Pharmacol. Ther.,11, 109–139 (1980).

    Google Scholar 

  180. B. N. C. Prochard, Drugs,28, Suppl. 2, 51–68 (1984).

    Google Scholar 

  181. B. N. C. Prochard, Clinical Pharmacology of Antianginal Drugs, Berlin (1985), pp. 385–458.

  182. C. Raper, G. A. McPherson, and I. Iakovidis, Eur. J. Pharmacol.,52, 241–248 (1978).

    Google Scholar 

  183. D. P. Rauls and J. K. Baker, J. Med. Chem.,22, 81–86 (1979).

    Google Scholar 

  184. W. J. Rzeszotatski, R. E. Gibson, D. A. Simms, et al., ibid.,26, 644–648 (1983).

    Google Scholar 

  185. K. Saameli, Helv. Physiol. Pharmacol. Acta,25, 219–221 (1967).

    Google Scholar 

  186. J. Sato, Y. Kobayoshi, T. Nogasaki, et al., Chem. Pharm. Bull.,20, 905–917 (1972).

    Google Scholar 

  187. C. F. Schwender, S. Farber, C. Blaum, and J. Shavel, J. Med. Chem.,13, 684–688 (1970).

    Google Scholar 

  188. A. Scriabine, M. L. Torchiana, J. M. Stavorski, et al., Arch. Int. Pharmacodyn. Ther.205 76–93 (1973).

    Google Scholar 

  189. D. G. Shand, Drugs,25, Suppl. 2, 92–103 (1983).

    Google Scholar 

  190. S. Shibamura, T. Chiba, I. Suzuki, et al., Jpn. J. Pharmacol.,28, Suppl., 139P (1978).

  191. G. Shtacher, R. Rubinstein, and P. Somani, J. Med. Chem.,21, 678–682 (1978).

    Google Scholar 

  192. V. Smeikal, Therapie,22, 2343–2347 (1967).

    Google Scholar 

  193. L. H. Smith and H. Tucker, J. Med. Chem.,20, 1653–1656 (1977).

    Google Scholar 

  194. L. H. Smith, J. Appl. Chem. Biotechnol.,28, 201–212 (1978).

    Google Scholar 

  195. P. Somani and A. R. Laddu, Eur. J. Pharmacol.,14, 209–216 (1971).

    Google Scholar 

  196. A. Squize and J. Kuqersmith, Mt. Sinai. J. Med.,22, 553–558 (1985).

    Google Scholar 

  197. U. Stache, W. Fritsch, and H. W. Fehlhaber, Arzneim.-Forsch.,37, 1217–1221 (1987).

    Google Scholar 

  198. K. Stock and E. Westermann, Biochem. Pharmacol.,14, 227–232 (1965).

    Google Scholar 

  199. T. L. Svendson, O. J. Hartling, J. Trap-Jensen, et al., Clin. Pharmacol. Ther.,29, 711–718 (1981).

    Google Scholar 

  200. C. S. Sweet, R. A. Hall, J. M. Columbo, et al., J. Pharmacol. Exp. Ther.,211, 195–199 (1979).

    Google Scholar 

  201. F. Takenaka, I. Ishikawa, and Y. Maruyama, Folia Pharmacol. Jap.,70, 385–397 (1974).

    Google Scholar 

  202. R. Takenaka and S. Tachikawa, Arzneim.-Forsch.,22, 1864–1869 (1972).

    Google Scholar 

  203. T. Takenaka, M. Asano, A. Berdeauz, and J.-F. Giudicelli, Eur. J. Pharmacol.,85, 35–50 (1982).

    Google Scholar 

  204. H. Tatsuno, K. Goto, K. Shigenobu, et al., J. Med. Chem.,20, 394–397 (1977).

    Google Scholar 

  205. N. E. Tayar, P. A. Carrupt, W. H. Vande, and B. Testa, ibid.,31, 2072–2081 (1988).

    Google Scholar 

  206. E. M. Taylor, D. Cameron, R. J. Eden, et al., J. Cardiovasc. Pharmacol.,3, 337–354 (1981).

    Google Scholar 

  207. U. M. Teotono, F. L. Polo, G. Steis, and D. Della Bella, J. Pharm. Pharmacol.,15, 26–33 (1963).

    Google Scholar 

  208. J. Trap-Jensen, J. E. Carlsen, T. L. Svendsen, and N. J. Christensen, Eur. J. Clin. Invest.,9, 181–189 (1979).

    Google Scholar 

  209. D. J. Triggle and C. R. Triggle, Chemical Pharmacology of the Synapse, London-New York (1976).

  210. H. Tucker, J. Med. Chem.,23, 1122–1126 (1980).

    Google Scholar 

  211. H. Tucker, ibid.,24, 1364–1368 (1981).

    Google Scholar 

  212. Y. Uchida, M. Nakamura, S. Shimizu, et al., Arch. Int. Pharmacodyn. Ther.,262, 132–149 (1983).

    Google Scholar 

  213. V. Vechetti, F. Lauria, R. Tommasini, and M. Bergamaschi, Eur. J. Med. Chem.,9, 501–509 (1974).

    Google Scholar 

  214. L. Villa, E. Grana, C. Torlasco, and P. Pratesi, Farmaco. Ed. Sci.,24, 349–355 (1969).

    Google Scholar 

  215. A. Von de Water, W. Janssens, J. von Neuten, et al., J. Cardiovasc. Pharmacol.,11, 552–563 (1988).

    Google Scholar 

  216. G. Von Hatfelder, H. Lessenich, and K. Schmitt, Arzneim.-Forsch.,22, 930–940 (1972).

    Google Scholar 

  217. A. Von Mollendorf, C. Huschka, E. Schroter, and U. Abchagen, Clin. Sci.,61, 477–479 (1981).

    Google Scholar 

  218. J. L. Wale, J. Convay, M. Reeves, and M. Austin, Clin. Pharmacol. Physiol.,6, 11–19 (1979).

    Google Scholar 

  219. L. R. Williams, B. V. Lap, C. H. Lim, et al., J. Med. Chem.,21, 1081–1084 (1978).

    Google Scholar 

  220. P. U. Witte, M. H. Budian, P. Hajdu, and V. Malerczyk, Naunyn-Schmiededberg's Arch. Pharmacol.,322, 131R (1983).

    Google Scholar 

  221. K. R. H. Wooldridge, Experientia,28, 1404–1409 (1972).

    Google Scholar 

  222. E. S. C. Wu, T. E. Cole, T. A. Davidson, et al., J. Med. Chem.,30, 788–792 (1987).

    Google Scholar 

  223. Y. Yabuuchi and D. Kinoshita, Jpn. J. Pharmacol.,6, 853–861 (1974).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 25, No. 5 pp. 21–31, May, 1991.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yuzhakov, S.D., Glushkov, R.G. & Mashkovskii, M.D. Structure-activity relationships in β-adrenoblockers. Pharm Chem J 25, 283–295 (1991). https://doi.org/10.1007/BF00772116

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00772116

Keywords

Navigation